TCR signaling without concomitant CD28 signaling was found to be the cause of FBXO38 downregulation.22 Persistent exposure to tumor antigen and low CD80/86 expression on tumor cells25 therefore could explain the reduced FBXO38 expression in TILs. This evidence concerns the gene FBXO38 and neoplasm.